Becton Dickinson & Co. closed 20.98% short of its 52-week high of $251.99, which the company reached on February 3rd.

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part ...

Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

This was the stock's third consecutive day of losses.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...

Becton, Dickinson and Co. also reported slightly higher pay for the device developer and manufacturer's median worker in ...

Barclays lowered the firm’s price target on Becton Dickinson (BDX) to $261 from $279 and keeps an Overweight rating on the shares. The firm ...

The solution enables the use of BD's Synapsis informatics with BD Phoenix M50 automated microbiology and rapid identification and AST on the BDXpert system.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

Pharma and biotech companies are breathing a sigh of relief after the tariffs announced by President Donald Trump Wednesday afternoon excludes pharmaceuticals.